GT Biopharma, Inc. (GTBP)

NASDAQ: GTBP · IEX Real-Time Price · USD
4.685
+0.205 (4.58%)
Mar 28, 2024, 12:00 PM EDT - Market open

GT Biopharma Market Cap

GT Biopharma has a market cap or net worth of $6.03 million as of March 28, 2024. Its market cap has decreased by -67.21% in one year.

Market Cap
6.03M
Enterprise Value
-7.88M
1-Year Change
-67.21%
Ranking
Category
Stock Price
$4.69

Market Cap Chart

Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.03M, a decrease of -92.75%. That is a compound annual growth rate of -35.40%.

History

DateMarket Cap% Change
Mar 27, 20246.00M-1.64%
Mar 26, 20246.10M-
Mar 25, 20246.10M-3.17%
Mar 22, 20246.30M18.87%
Mar 21, 20245.30M-8.62%
Mar 20, 20245.80M-6.45%
Mar 19, 20246.20M1.64%
Mar 18, 20246.10M-4.69%
Mar 15, 20246.40M-1.54%
Mar 14, 20246.50M3.17%
Mar 13, 20246.30M-11.27%
Mar 12, 20247.10M5.97%
Mar 11, 20246.70M11.67%
Mar 8, 20246.00M-1.64%
Mar 7, 20246.10M1.67%
Mar 6, 20246.00M1.69%
Mar 5, 20245.90M-6.35%
Mar 4, 20246.30M3.28%
Mar 1, 20246.10M5.17%
Feb 29, 20245.80M-
Feb 28, 20245.80M1.75%
Feb 27, 20245.70M3.64%
Feb 26, 20245.50M3.77%
Feb 23, 20245.30M-8.62%
Feb 22, 20245.80M3.57%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Oragenics 6.36M
ZyVersa Therapeutics 6.20M
Universe Pharmaceuticals INC 6.16M
Azitra 6.14M
Pulmatrix 6.10M
Xenetic Biosciences 6.09M
Vivos Therapeutics 6.06M
Kineta 6.05M
Market Cap Rankings